within Pharmacolibrary.Drugs.ATC.D;

model D10AF06
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.9,
    Cl             = 2.0,
    adminDuration  = 600,
    adminMass      = 1.0,
    adminCount     = 1,
    Vd             = 0.0002,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.006666666666666667,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Sulfacetamide is a sulfonamide antibiotic primarily used topically for the treatment of bacterial infections of the eye (such as conjunctivitis) and skin (such as acne). Systemic use has largely fallen out of favor due to the development of safer and more effective antibiotics, and it is not routinely used orally today. It is still approved for topical use.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for sulfacetamide based on extrapolation from sulfonamide antibiotic class; no direct publication of systemic human PK after topical use. Parameters here reflect standard adult values for systemic (oral) administration from analogous sulfonamides.</p><h4>References</h4><ol><li><p>Nadeau, D, &amp; Marchand, C (1975). Change in the kinetics of sulphacetamide tissue distribution in Walker tumor-bearing rats. <i>Drug metabolism and disposition: the biological fate of chemicals</i> 3(6) 565–576. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/1234/&quot;>https://pubmed.ncbi.nlm.nih.gov/1234</a></p></li><li><p>Marchand, C, &amp; Nadeau, D (1976). The distribution and kinetics of sulphacetamide in leukaemic mice. <i>British journal of pharmacology</i> 56(4) 423–429. DOI:<a href=&quot;https://doi.org/10.1111/j.1476-5381.1976.tb07453.x&quot;>10.1111/j.1476-5381.1976.tb07453.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/1260222/&quot;>https://pubmed.ncbi.nlm.nih.gov/1260222</a></p></li><li><p>Boycov, DE, et al., &amp; Perlovich, GL (2025). Novel Drug-Drug Cocrystalline Forms of Carbamazepine with Sulfacetamide: Preparation, Characterization, and In Vitro/In Vivo Performance Evaluation. <i>Pharmaceutics</i> 17(5) –. DOI:<a href=&quot;https://doi.org/10.3390/pharmaceutics17050678&quot;>10.3390/pharmaceutics17050678</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/40430968/&quot;>https://pubmed.ncbi.nlm.nih.gov/40430968</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end D10AF06;
